Open AccessAbstract 3938: Anti-angiogenic therapy combination with hypoxia-regulating agent leads to improved tumor regression in a murine model or renal carcinoma
Author(s) -
Imane Nafia,
Assia Chaïbi,
Doriane Bortolotto,
Christophe Rey,
Alban Bessede
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-3938
Subject(s) - sunitinib , hypoxia (environmental) , medicine , cancer research , everolimus , angiogenesis , tumor hypoxia , tumor microenvironment , pi3k/akt/mtor pathway , renal cell carcinoma , pharmacology , cancer , pathology , biology , chemistry , apoptosis , biochemistry , organic chemistry , oxygen , radiation therapy